SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-016958
Filing Date
2022-04-29
Accepted
2022-04-29 16:15:54
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A edge20002463x2_defa14a.htm DEFA14A 10644
2 edge20002463x2_nc01.jpg GRAPHIC 1861914
3 edge20002463x2_nc02.jpg GRAPHIC 1645526
  Complete submission text file 0001140361-22-016958.txt   4838585
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-31326 | Film No.: 22875652
SIC: 2836 Biological Products, (No Diagnostic Substances)